Virtus ETF Advisers’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-2,684
| Closed | -$117K | – | 469 |
|
2023
Q3 | $117K | Sell |
2,684
-268
| -9% | -$11.7K | 0.07% | 322 |
|
2023
Q2 | $107K | Buy |
2,952
+634
| +27% | +$22.9K | 0.06% | 352 |
|
2023
Q1 | $86.2K | Sell |
2,318
-885
| -28% | -$32.9K | 0.05% | 372 |
|
2022
Q4 | $145K | Buy |
3,203
+1,214
| +61% | +$55K | 0.08% | 354 |
|
2022
Q3 | $139K | Buy |
1,989
+14
| +0.7% | +$978 | 0.06% | 365 |
|
2022
Q2 | $133K | Buy |
1,975
+861
| +77% | +$58K | 0.05% | 344 |
|
2022
Q1 | $92K | Sell |
1,114
-69
| -6% | -$5.7K | 0.04% | 317 |
|
2021
Q4 | $174K | Sell |
1,183
-66
| -5% | -$9.71K | 0.07% | 267 |
|
2021
Q3 | $221K | Sell |
1,249
-69
| -5% | -$12.2K | 0.1% | 242 |
|
2021
Q2 | $213K | Buy |
1,318
+40
| +3% | +$6.46K | 0.09% | 302 |
|
2021
Q1 | $219K | Buy |
1,278
+22
| +2% | +$3.77K | 0.09% | 313 |
|
2020
Q4 | $276K | Sell |
1,256
-1,764
| -58% | -$388K | 0.11% | 262 |
|
2020
Q3 | $501K | Sell |
3,020
-404
| -12% | -$67K | 0.26% | 138 |
|
2020
Q2 | $391K | Buy |
3,424
+213
| +7% | +$24.3K | 0.19% | 206 |
|
2020
Q1 | $247K | Sell |
3,211
-467
| -13% | -$35.9K | 0.1% | 253 |
|
2019
Q4 | $474K | Buy |
3,678
+988
| +37% | +$127K | 0.08% | 210 |
|
2019
Q3 | $210K | Sell |
2,690
-149
| -5% | -$11.6K | 0.04% | 238 |
|
2019
Q2 | $292K | Sell |
2,839
-3,667
| -56% | -$377K | 0.06% | 228 |
|
2019
Q1 | $477K | Sell |
6,506
-778
| -11% | -$57K | 1.01% | 31 |
|
2018
Q4 | $309K | Sell |
7,284
-2,291
| -24% | -$97.2K | 0.05% | 102 |
|
2018
Q3 | $451K | Sell |
9,575
-6,854
| -42% | -$323K | 0.05% | 137 |
|
2018
Q2 | $810K | Sell |
16,429
-26,707
| -62% | -$1.32M | 0.72% | 24 |
|
2018
Q1 | $1.32M | Buy |
43,136
+23,350
| +118% | +$717K | 1.15% | 11 |
|
2017
Q4 | $361K | Buy |
+19,786
| New | +$361K | 0.45% | 75 |
|
2016
Q2 | – | Sell |
-7,828
| Closed | -$168K | – | 152 |
|
2016
Q1 | $168K | Buy |
+7,828
| New | +$168K | 0.23% | 109 |
|